MedTrace Logo

Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)

NCT01172743 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2020-07-31

No results posted yet for this study

Summary

This protocol is designed to gather a small amount of blood for extraction of DNA for the study of the genetic basis of diabetes. The study population will include individuals with known diabetes, and controls without diabetes. Investigators aim to understand the genetics of diabetes, and will use the cells and serum from this blood to perform genotyping and gene expression studies of individuals with diabetes and relevant controls.

Conditions

Sponsors & Collaborators

  • Weill Cornell Medical College in Qatar

    collaborator OTHER

  • Hamad Medical Corporation

    collaborator INDUSTRY

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Ronald G Crystal, MD · Weill Cornell Medical College, NY and Qatar

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Qatar

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01172743 on ClinicalTrials.gov